Description
Hymecromone (also known as 4-methylumbelliferone or 4-MU) is a synthetic coumarin derivative commonly used in biomedical research, particularly for its choleretic, antifibrotic, and hepatoprotective properties. It is studied for stimulating bile secretion, reducing liver inflammation, and modulating hyaluronic acid synthesis.
This product contains 6 oral tablets, each delivering 200?mg of hymecromone. Manufactured under GMP standards in China by Wanbangde Pharmaceutical Group, it is approved by the NMPA (Chinese FDA) under H13022246.
? Ideal for use in liver function studies, hepatic fibrosis models, bile secretion assays, and pharmaceutical R&D.
Hymecromone Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Hymecromone Tablets (Fujian) |
| Generic Name | Hymecromone / 4-Methylumbelliferone |
| CAS Number | 90-33-5 |
| Molecular Formula | C10H8O3 |
| Molecular Weight | 176.17 g/mol |
| Strength | 200?mg per tablet |
| Dosage Form | Oral tablet |
| Pack Size | 6 tablets per box |
| Approval Number | H13022246 (NMPA) |
| Drug Code | 86902779000147 |
| Manufacturer | Wanbangde Pharmaceutical Group Co., Ltd. |
| Barcode | 6920552403491 |
| Storage Conditions | Store ? 25?°C in dry place; avoid direct sunlight |
| Intended Use | For lab R&D in hepatology, bile secretion, and fibrosis |
Hymecromone Tablets Mechanism of Action
Hymecromone enhances bile acid secretion by inhibiting hyaluronic acid synthesis, reducing bile duct resistance, and improving bile flow. It also exhibits anti-inflammatory effects on hepatocytes and fibrotic tissues. This makes it a promising research compound for liver diseases, especially cholestasis, hepatofibrosis, and NAFLD models.
Research Applications
Hepatic fibrosis inhibition via hyaluronic acid modulation
Choleretic activity studies in experimental bile flow assays
NAFLD and liver injury models
Antifibrotic drug development screening
Liver inflammation suppression in chemically-induced models
Safety & Handling
Suggested Lab Use: Refer to institutional preclinical guidelines
Observed Adverse Reactions (in high dose models): Gastrointestinal upset, hypersensitivity
PPE Required: Gloves, mask, protective eyewear when handling
Shelf Life: 24–36 months when sealed and stored properly
Core Keywords
Hymecromone tablets, 4-MU tablets, 4-methylumbelliferone 200mg, CAS 90-33-5, choleretic research compound, liver fibrosis model drug, bile secretion enhancer, hymecromone hepatoprotection
Research Use Disclaimer
This product is for research and laboratory use only. It is not approved for therapeutic, diagnostic, or veterinary use. Misuse may pose health and legal risks. Use only under institutional or laboratory supervision.


Reviews
There are no reviews yet.